Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Overview of Lipid Metabolism

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Lipid Absorption

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...

Lipid Digestion

Lipid Digestion

Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Socioeconomic Factors Impacting Survival in Patients with Hepatocellular Carcinoma Treated with Locoregional Therapies: A Single-Center Study.

Journal of vascular and interventional radiology : JVIR·2026

Same author

From technology adoption to noise reduction: Behavioral and psychological dimensions of clinical artificial intelligence deployment.

European journal of internal medicine·2026

Same author

Thirty-day outcomes following transcarotid artery revascularization with integrated embolic protection: The PERFORMANCE III study.

Journal of vascular surgery·2026

Same author

Effects of inflammatory phenotypes in acute respiratory distress syndrome on mortality and partitioning of lung and chest wall mechanics in patients in the USA and Canada: a retrospective cohort study.

The Lancet. Respiratory medicine·2026

Same author

Physical activity in migraine: Identifying an engagement threshold and patient clusters in a population-based cohort.

Cephalalgia : an international journal of headache·2026

Same author

Postoperative antibiotic prophylaxis following cardiac implantable electronic device implantation and the risk of device infection.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026

Search research articles

Related Experiment Video

Updated: Jul 4, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

A national study on lipid management.

Alan B Jotkowitz¹, Victor Novack, Gad Rabinowitz

¹Department of Internal Medicine F, Soroka University Medical Center, Faculty of the Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel. ajotkowitz@hotmail.com

European Journal of Internal Medicine

|June 14, 2008

Summary

This study shows improved LDL cholesterol testing and treatment goal achievement for cardiovascular disease prevention. Continued efforts are necessary to further enhance patient outcomes in hyperlipidemia management.

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Related Experiment Videos

Last Updated: Jul 4, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Area of Science:

Cardiology
Preventive Medicine
Public Health

Background:

Hyperlipidemia is a significant contributor to cardiovascular morbidity in Western populations.
Assessing LDL cholesterol measurement rates and goal attainment is crucial for effective cardiovascular disease (CVD) prevention.
This study focuses on primary and secondary prevention strategies for hyperlipidemia.

Purpose of the Study:

To determine the percentage of adults undergoing regular LDL cholesterol measurements.
To evaluate the proportion of diabetic and post-angioplasty patients achieving target LDL cholesterol levels.
To analyze trends in LDL measurement and treatment goal attainment over time.

Main Methods:

Utilized a national database to extract data on LDL cholesterol testing rates.
Assessed LDL cholesterol levels and treatment goal attainment in diabetic and post-angioplasty cohorts.
Collected data from patients with acute coronary syndrome (ACS) admitted between 2000-2004.

Main Results:

In 2005, LDL cholesterol measurement was documented in 64.6% of adults aged 35-44 and 79.6% aged 45-54.
86.9% of diabetic patients had at least one annual LDL measurement; statin therapy use increased significantly post-ACS (87%).
Among post-PTCA patients, 57.8% achieved LDL <100 mg/dl, with high rates of statin prescription and LDL measurement.

Conclusions:

Significant improvements observed in primary and secondary prevention of CVD through increased LDL measurement and goal attainment.
While progress has been made, further interventions are required to optimize hyperlipidemia management.
The findings highlight the importance of regular monitoring and adherence to treatment goals for reducing cardiovascular risk.